Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial

Diabetes care

Volumn 42, Issue 4, 2019, Pages e53-e55

  Inzucchi, Silvio E ^a   Wanner, Christoph ^b   Hehnke, Uwe ^c   Zwiener, Isabella ^c   Kaspers, Stefan ^c   Clark, Douglas ^c   George, Jyothis T ^c   Zinman, Bernard ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85063607974     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc18-1355     Document Type: Letter

References (0)